Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Biorestorative Therapies, Inc. (BRTX) had Stock-Based Compensation of $2.88M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$0.01M |
|
$-3.04M |
|
$0.01M |
|
$0.00M |
|
$3.72M |
|
$-3.71M |
|
$0.67M |
|
$-3.04M |
|
$-3.04M |
|
$-3.04M |
|
$-3.04M |
|
$-3.04M |
|
$-3.04M |
|
$-3.71M |
|
$-3.66M |
|
9.12M |
|
9.12M |
|
$-0.33 |
|
$-0.33 |
|
| Balance Sheet Financials | |
$4.71M |
|
$0.31M |
|
$0.94M |
|
$5.64M |
|
$3.44M |
|
-- |
|
-- |
|
$3.44M |
|
$2.19M |
|
$1.65M |
|
$2.21M |
|
7.98M |
|
| Cash Flow Statement Financials | |
$-8.37M |
|
$6.50M |
|
$1.93M |
|
$0.55M |
|
$0.60M |
|
$0.05M |
|
|
Stock-Based Compensation |
$2.88M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.37 |
|
-- |
|
-- |
|
-- |
|
-- |
|
10.42% |
|
-31432.29% |
|
-31432.29% |
|
-- |
|
-25748.11% |
|
-25748.11% |
|
$-8.41M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.88 |
|
102.20 |
|
-138.54% |
|
-184.10% |
|
-53.84% |
|
-137.67% |
|
$0.28 |
|
$-0.92 |
|
$-0.92 |
|